- Country: USA
- Summary: Japanese Encephalitis Vaccine (JEV)
- UST Ref No: 125274233
- Deadline: 26 Sep 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: SPE2DP-26-R-0JEV
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
Sources Sought Notice for the Japanese Encephalitis Vaccine (JEV)
NSN: 6505-01-607-7018
ITEM IDENTIFICATION: Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe
The Defense Logistics Agency Troop Support is seeking sources capable of providing the Japanese Encephalitis Vaccine (JEV). DLA Troop Support is contemplating awarding a one-year base indefinite delivery, indefinite quantity contract for the JEV. The contract minimum quantity is 200,060 each. The estimated quantity is 208,320 each and the contract maximum is 300,300 each. However, the quantity may increase or decrease as the Services requirements change.
SALIENT CHARACTERISTICS
Shall be Japanese Encephalitis Virus Vaccine, Purified, Inactivated.
Shall be FDA-approved for active immunization against Japanese Encephalitis disease.
Shall be FDA-approved for administration to persons 2 months of age and up.
Shall be Vero Cell culture derived.
Shall be a sterile suspension.
Shall not contain any stabilizers.
Shall be Thimerosal/Preservative-free and Latex free.
Shall be suitable for intramuscular administration.
Shall be supplied as a sterile 0.5 ml suspension in a pre-filled syringe (Type 1 glass) with a plunger stopper (chlorobutyl elastomer) with or without a separate needle. Children 2 months to Shall have an expiration dating period of 24 months. Not less than 21 months of the expiration dating period shall remain at time of delivery to the Government.
Material shall be shipped under constant refrigeration: 2° - 8° C (35° - 46° F). No excursions permitted.
Do Not Freeze. Protect from light.
Unit. Each. One each (syringe) containing a single-dose pre-filled syringe, as specified, constitutes one unit.
For additional requirements please see the attachment to this announcement titled “JEV MPID 4”.
Awardee shall have FDA approval to sell the JEV before award decision.
If your f... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINJapanese Encephalitis Vaccine (JEV) - USA Tender
The DEPT OF DEFENSE | DEFENSE LOGISTICS AGENCY, a Government sector organization in USA, has announced a new tender for Japanese Encephalitis Vaccine (JEV). This tender is published on USARFP under UST Ref No: 125274233 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-26.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
